site stats

Syros pharmaceuticals ticker

WebApr 6, 2024 · A high-level overview of Syros Pharmaceuticals, Inc. (SYRS) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. WebSep 16, 2024 · CAMBRIDGE, Mass.-- (BUSINESS WIRE)-- Syros Pharmaceuticals, Inc. (NASDAQ:SYRS), a leader in the development of medicines that control the expression of genes, today announced the closing of its merger with Tyme Technologies, Inc., pursuant to which Syros acquired TYME, including its pipeline assets and net cash at closing of …

Syros Announces Closing of Merger with Tyme Technologies and …

WebFeb 4, 2024 · Syros Pharmaceuticals, Inc. annonce ses résultats pour le quatrième trimestre clos le 3.. 03/02: Syros Pharmaceuticals, Inc. annonce ses résultats pour l'année complète se terminant le.. 01/26: Syros Pharmaceuticals obtient le label Fast Track de la FDA pour le tamibarotène dans l.. 01/26 WebOct 3, 2024 · Syros Pharmaceuticals News: Why SYRS Stock Is Shooting 16% Higher Today. By William White, InvestorPlace Writer Dec 18, 2024. Syros Pharmaceuticals (SYRS) news for Wednesday about plans for ... eclipse クラスファイル 場所 https://aweb2see.com

SYRS - Stock quote for SYROS PHARMACEUTICALS, INC. - MSN

WebApr 4, 2024 · Syros Pharmaceuticals. stock was originally listed at a price of $181.50 in Jun 30, 2016. If you had invested in Syros Pharmaceuticals stock at $181.50 , your return over … WebJul 5, 2024 · CAMBRIDGE, Mass. & BEDMINSTER, N.J.-- (BUSINESS WIRE)-- Syros Pharmaceuticals (NASDAQ:SYRS), a leader in the development of medicines that control the expression of genes, and TYME Technologies, Inc. (NASDAQ:TYME), today announced that the companies have entered into a definitive merger agreement pursuant to which Syros … WebSep 15, 2024 · Following the closing of the Merger, the combined company will trade on The Nasdaq Global Select Market under the ticker symbol “SYRS,” and will be led by Syros’ existing management team,... eclipse コードテンプレート

Syros Pharmaceuticals (SYRS) Price To Cash Flow - Zacks.com

Category:Syros and Tyme Technologies Announce Stockholder Approval of …

Tags:Syros pharmaceuticals ticker

Syros pharmaceuticals ticker

SYRS Stock Forecast, Price & News (Syros Pharmaceuticals) - MarketB…

WebWe are focused on applying this approach to developing new standards of care for the frontline treatment of patients with hematologic malignancies. Driven by the motivation to help patients with blood disorders that have largely eluded current targeted approaches, we are advancing our late-stage clinical pipeline to provide new treatment options. WebMar 2, 2024 · Syros Pharmaceuticals, Inc. is a biopharmaceutical company. The Company is focused on developing new standards of care for the frontline treatment of patients with …

Syros pharmaceuticals ticker

Did you know?

WebSyros Pharmaceuticals, Inc. engages in the development of gene control therapies for cancer and diseases. Its product candidates include SY-1425, SY-2101, and SY-5609. The … WebSyros Pharmaceuticals, Inc. (SYRS) Stock Price, News, Quote & History - Yahoo Finance U.S. markets open in 6 hours 59 minutes Dow Futures Nasdaq Futures Russell 2000 Futures … Find the latest Syros Pharmaceuticals, Inc. (SYRS) stock discussion in Yahoo … Discover historical prices for SYRS stock on Yahoo Finance. View daily, weekly or … Get the detailed quarterly/annual income statement for Syros Pharmaceuticals, … Find out the direct holders, institutional holders and mutual fund holders for … See the company profile for Syros Pharmaceuticals, Inc. (SYRS) including … See Syros Pharmaceuticals, Inc. (SYRS) stock analyst estimates, including … Syros Pharmaceuticals, Inc. (NASDAQ:SYRS) Q4 2024 Earnings Call … Find out all the key statistics for Syros Pharmaceuticals, Inc. (SYRS), including … View the basic SYRS option chain and compare options of Syros … Find the latest Syros Pharmaceuticals, Inc. (SYRS) stock quote, history, news and …

WebOct 18, 2024 · Syros Pharmaceuticals Inc is a biopharmaceutical company engaged in a non-coding regulatory region of the genome controlling the activation and repression of … WebApr 7, 2024 · Syros Pharmaceuticals Inc is a biopharmaceutical company engaged in a non-coding regulatory region of the genome controlling the activation and repression of genes. …

WebMar 24, 2024 · Syros Pharmaceuticals - SYRS - Stock Price Today - Zacks Syros Pharmaceuticals (SYRS) (Delayed Data from NSDQ) $2.74 USD -0.07 (-2.49%) Updated … Web1 day ago · Price To Cash Flow is a widely used stock evaluation measure. Find the latest Price To Cash Flow for Syros Pharmaceuticals (SYRS)

WebMar 27, 2024 · Syros Pharmaceuticals (SYRS) (Real Time Quote from BATS) $3.61 USD +0.01 (0.28%) Updated Feb 28, 2024 10:22 AM ET Add to portfolio Zacks Rank: 3-Hold 3 Style Scores: F Value F Growth C...

WebMar 2, 2024 · Syros Pharmaceuticals, Inc., which belongs to the Zacks Medical - Biomedical and Genetics industry, posted revenues of $-0.75 million for the quarter ended December 2024, missing the Zacks... eclipse コードフォーマッターWebThe price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company). eclipse コメントアウト 解除 ショートカットWebFollowing my experience in 2016, I was invited to apply for the expo of 2024. Again I worked directly under the team that managed, organised and ran … eclipse コミット コメント 変更 cvs